Dry eye management in a Sjögren’s syndrome mouse model by inhibition of p38-MAPK pathway
Open Access
- 20 January 2014
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 5
Abstract
Background: To investigate the therapeutic effect of p38-MAPK inhibitor, SB203580, on dry eye in a mouse model of Sjogren's syndrome (MRL/lpr mice). Methods: 18 female BALB/c mice and 44 female MRL/lpr mice were included. Mice were randomly assigned to the control or treatment group. The expression of phospho-p38 MAPK in lacrimal glands of BALB/c mice was determined by Western blot analysis following IL-1 beta treatment at various time points. Different doses of SB203580 were injected into lacrimal glands of MRL/lpr mice and phenol red thread test was performed seven days post-injection. Moreover, the levels of acetylcholine and norepinephrine expression in lacrimal glands of MRL/lpr mice were measured using spectrofluoremetric assay and the histopathology of lacrimal glands was also evaluated. Results: The expression of p-p38 MAPK in lacrimal glands of BALB/c mice gradually increased following incubation with IL-1 beta ex vivo. Injection of SB203580 into lacrimal glands significantly improved the results of phenol red thread test in MRL/lpr mice. In addition, the secretions of acetylcholine and norepinephrine increased significantly compared to the control group. Less lymphocytes infiltration was observed in pathological section of lacrimal glands following SB203580 injection. Conclusions: Our results indicate that the activation of p38-MAPK pathway plays an important role in dry eye of a Sjogren's syndrome mouse model. Inhibition of p38-MAPK pathway by SB203580 might have potential therapeutic effect on Sjogren's syndrome associated dry eye. Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1256849631103092.Keywords
This publication has 18 references indexed in Scilit:
- Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndromeNature Genetics, 2013
- Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisitedDiagnostic Pathology, 2009
- Management and Therapy of Dry Eye Disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)The Ocular Surface, 2007
- The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007)The Ocular Surface, 2007
- c‐Jun NH2‐terminal kinase mediates interleukin‐1β‐induced inhibition of lacrimal gland secretionJournal of Neurochemistry, 2005
- Current issues in the diagnosis and treatment of Sjögrenʼs syndromeCurrent Opinion in Rheumatology, 1999
- Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1β?Progress in Neurobiology, 1998
- Immunohistochemical and enzymehistochemical studies of peptidergic, aminergic and cholinergic innervation of the lacrimal gland of the monkey (Macaca fuscata)Journal of the Autonomic Nervous System, 1992
- Vasoactive Intestinal Polypeptide and the Innervation of the Human Lacrimal GlandArchives of Ophthalmology (1950), 1988
- Functional Innervation of the Lacrimal Gland in the CatArchives of Ophthalmology (1950), 1966